
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (CC BY).
ORIGINAL RESEARCH
Assessment of efficacy of composite dressing manufactured from hydroalginateand silver-coated fibers in treatment of patients with atopic dermatitis
1 Department of Oncology, Hematology and Radiotherapy, Pediatric Faculty,
Pirogov Russian National Research University, Moscow, Russia
2 Department of Microbiology and Virology, Pediatric Faculty,
Pirogov Russian National Research Medical University, Moscow, Russia
Correspondence should be addressed:
Leninskii prospekt, d. 117, Moscow, Russia, 117997; e-mail is not indicated
The aim of the research was studying of the clinical and laboratory parameters, including the assessment of a level of skin contamination with S. aureus in 25 children with atopic dermatitis, before and after the use of composite dressings manufactured from hydroalginate and silver-coated fibers. The SCORAD index before the treatment was, on average, 34.4 ± 4.0. S. aureus was detected in 18 children (72 %) with a mean concentration of 4.3 ± 4.0 CFU/cm2. Patients' affected skin areas were covered with Silvercel dressings (Johnson & Johnson) for 7 days. A microbiological test was repeated thereafter. S. aureus was detected only in 8 patients after the treatment, the level of skin contamination with S. aureus being 2.3 ± 0.2 CFU/cm2 (p < 0.05). The treatment was well-tolerated by all children. Twenty patients (80 %) had an improvement of their skin condition. The SCORAD index after the treatment was 20.35 ± 8.5 (p < 0.05). Positive changes in clinical and laboratory parameters allows to conclude that this approach is effective and safe in treatment for atopic dermatitis aggravated by a bacterial infection.
Keywords: atopic dermatitis, S. aureus, causal treatment, alginate dressings, silver-coated fibers